My bookmarksSign up free

Commission Implementing Regulation (EU) 2019/707 of 7 May 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, desmedipham, dimethoate, dimethomorph, diuron, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, formetanate, metalaxyl-m, methiocarb, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole, s-metolachlor and tebuconazole (Text with EEA relevance.)

Commission Implementing Regulation (EU) 2019/707 of 7 May 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, desmedipham, dimethoate, dimethomorph, diuron, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, formetanate, metalaxyl-m, methiocarb, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole, s-metolachlor and tebuconazole (Text with EEA relevance.)

Implementing Regulation (EU) 2019/707 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

ANNEX Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) in the sixth column, expiration of approval, of row 35, Famoxadone, the date is replaced by ‘30 June 2020’; (2) in the sixth column, expiration of approval, of row 37, Metalaxyl-M, the date is replaced by ‘30 June 2020’; (3) in the sixth column, expiration of approval, of row 39, Flumioxazine, the date is replaced by ‘30 June 2020’; (4) in the sixth column, expiration of approval, of row 44, Foramsulfuron, the date is replaced by ‘31 July 2020’; (5) in the sixth column, expiration of approval, of row 46, Cyazofamid, the date is replaced by ‘31 July 2020’; (6) in the sixth column, expiration of approval, of row 83, Alpha-cypermethrin, the date is replaced by ‘31 July 2020’; (7) in the sixth column, expiration of approval, of row 84, Benalaxyl, the date is replaced by ‘31 July 2020’; (8) in the sixth column, expiration of approval, of row 85, Bromoxynil, the date is replaced by ‘31 July 2020’; (9) in the sixth column, expiration of approval, of row 86, Desmedipham, the date is replaced by ‘31 July 2020’; (10) in the sixth column, expiration of approval, of row 88, Phenmedipham, the date is replaced by ‘31 July 2020’; (11) in the sixth column, expiration of approval, of row 97, S-metolachlor, the date is replaced by ‘31 July 2020’; (12) in the sixth column, expiration of approval, of row 99, Etoxazole, the date is replaced by ‘31 July 2020’; (13) in the sixth column, expiration of approval, of row 109, Bifenazate, the date is replaced by ‘31 July 2020’; (14) in the sixth column, expiration of approval, of row 110, Milbemectin, the date is replaced by ‘31 July 2020’; (15) in the sixth column, expiration of approval, of row 141, Fenamiphos, the date is replaced by ‘31 July 2020’; (16) in the sixth column, expiration of approval, of row 142, Ethephon, the date is replaced by ‘31 July 2020’; (17) in the sixth column, expiration of approval, of row 145, Captan, the date is replaced by ‘31 July 2020’; (18) in the sixth column, expiration of approval, of row 146, Folpet, the date is replaced by ‘31 July 2020’; (19) in the sixth column, expiration of approval, of row 147, Formetanate, the date is replaced by ‘31 July 2020’; (20) in the sixth column, expiration of approval, of row 148, Methiocarb, the date is replaced by ‘31 July 2020’; (21) in the sixth column, expiration of approval, of row 149, Dimethoate, the date is replaced by ‘31 July 2020’; (22) in the sixth column, expiration of approval, of row 150, Dimethomorph, the date is replaced by ‘31 July 2020’; (23) in the sixth column, expiration of approval, of row 152, Metribuzin, the date is replaced by ‘31 July 2020’; (24) in the sixth column, expiration of approval, of row 153, Phosmet, the date is replaced by ‘31 July 2020’; (25) in the sixth column, expiration of approval, of row 154, Propamocarb, the date is replaced by ‘31 July 2020’; (26) in the sixth column, expiration of approval, of row 156, Pirimiphos-methyl, the date is replaced by ‘31 July 2020’; (27) in the sixth column, expiration of approval, of row 158, Beflubutamid, the date is replaced by ‘31 July 2020’; (28) in the sixth column, expiration of approval, of row 163, Benthiavalicarb, the date is replaced by ‘31 July 2020’; (29) in the sixth column, expiration of approval, of row 164, Boscalid, the date is replaced by ‘31 July 2020’; (30) in the sixth column, expiration of approval, of row 166, Fluoxastrobin, the date is replaced by ‘31 July 2020’; (31) in the sixth column, expiration of approval, of row 167, Paecilomyces lilacinus strain 251, the date is replaced by ‘31 July 2020’; (32) in the sixth column, expiration of approval, of row 168, Prothioconazole, the date is replaced by ‘31 July 2020’; (33) in the sixth column, expiration of approval, of row 192, Diuron, the date is replaced by ‘30 September 2020’; (34) in the sixth column, expiration of approval, of row 268, Tebuconazole, the date is replaced by ‘31 August 2020’.

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next